Dapiprazole hydrochloride - ≥98%, high purity , Alpha-1a adrenergic receptor antagonist, CAS No.72822-13-0, Alpha-1a adrenergic receptor antagonist

  • ≥98%
Item Number
D275147
Grouped product items
SKUSizeAvailabilityPrice Qty
D275147-10mg
10mg
4
$53.90
D275147-25mg
25mg
4
$107.90
D275147-50mg
50mg
3
$165.90
D275147-100mg
100mg
2
$246.90
D275147-250mg
250mg
2
$555.90
D275147-500mg
500mg
2
$1,000.90

Selective α 1 -adrenoreceptor antagonist

Basic Description

SynonymsAKOS000119855 | CAS-72822-13-0 | DAPIPRAZOLE HYDROCHLORIDE [ORANGE BOOK] | DAPIPRAZOLE HYDROCHLORIDE [MART.] | 3-(2-(4-o-tolylpiperazin-1-yl)ethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride | 5,6,7,8-Tetrahydro-3-[2-(4-O-tolyl-1-pipe
Specifications & Purity≥98%
Biochemical and Physiological MechanismsSelective α 1 -adrenoreceptor antagonist. Shows 10-fold selectivey for A and D subtypes over B subtype. Antipsychotic agent. Active in vivo and in vitro .
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Action TypeANTAGONIST
Mechanism of actionAlpha-1a adrenergic receptor antagonist
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid488195872
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488195872
IUPAC Name 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride
INCHI InChI=1S/C19H27N5.ClH/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19;/h2-3,6-7H,4-5,8-15H2,1H3;1H
InChi Key ZIODNPFQZIHCOE-UHFFFAOYSA-N
Canonical SMILES CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4.Cl
Isomeric SMILES CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4.Cl
PubChem CID 6917787
Molecular Weight 361.91

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

12 results found

Lot NumberCertificate TypeDateItem
F2315731Certificate of AnalysisMay 09, 2024 D275147
F2315748Certificate of AnalysisMar 22, 2024 D275147
F2315839Certificate of AnalysisMar 22, 2024 D275147
F2315841Certificate of AnalysisMar 22, 2024 D275147
F2315844Certificate of AnalysisMar 22, 2024 D275147
F2315875Certificate of AnalysisMar 22, 2024 D275147
F2316349Certificate of AnalysisMar 22, 2024 D275147
F2316339Certificate of AnalysisMar 07, 2024 D275147
F2315882Certificate of AnalysisMar 07, 2024 D275147
F2316348Certificate of AnalysisMar 07, 2024 D275147
F2315745Certificate of AnalysisMar 07, 2024 D275147
F2315729Certificate of AnalysisMar 07, 2024 D275147

Show more⌵

Related Documents

Reviews

Customer Reviews

References

1. Soltani A et al..  (2021)  Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors?.  Pathophysiology,  28  (34-49).  [PMID:35366268]
2. Jaromi L et al..  (2021)  KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer..  Int J Mol Sci,  22  (10):   [PMID:34065402]
3. Abdelwahab EMM et al..  (2019)  Wnt signaling regulates trans-differentiation of stem cell like type 2 alveolar epithelial cells to type 1 epithelial cells..  Respir Res,  20  (204).  [PMID:31492143]

Solution Calculators